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Abstract
Biochemical gradients are ubiquitous in biology. At the tissue level, they dictate differentiation 
patterning or cell migration. Recapitulating in vitro the complexity of such concentration profiles 
with great spatial and dynamic control is crucial in order to understand the underlying mechanisms 
of biological phenomena. Here we describe a microfluidic design capable of generating diffusion-
driven, simultaneous or sequential, orthogonal linear concentration gradients in a three-
dimensional cell-embedded scaffold. Formation and stability of the orthogonal gradients are 
demonstrated by computational and fluorescent dextran-based characterizations. We then explore 
system utility in two biological systems. First, we subject stem cells to orthogonal gradients of 
morphogens in order to mimic the localized differentiation of motor neurons in the neural tube. 
Similarly to in vivo, motor neurons preferentially differentiated in regions of high concentration of 
retinoic acid and smoothened agonist (acting as sonic hedgehog), in a concentration-dependent 
fashion. We then apply a rotating gradient to HT1080 cancer cells and investigate the change in 
migration direction as the cells adapt to a new chemical environment. We report that the response 
time is ~4h. These two examples demonstrate the versatility of this new design that could also 
prove useful in many applications including tissue engineering and drug screening.
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1. Introduction
The complexity of biological tissue shapes and functions arises from the intricate 
superposition of stimuli presented to them in a space- and time-dependent fashion. These 
stimuli dynamically evolve as their sources and recipients move with respect to one another 
and regulate their response. Such cues include mechanical stretching or compression, 
electrical excitation or cell-cell signaling by paracrine or autocrine mechanisms. Important 
signaling cues are often provided as concentration gradients, which are ubiquitous in 
biology. Fundamental at the subcellular level to ensure homeostasis or ion transport,[1] they 
are also involved in long range cell signaling. Our ability to understand and manipulate these 
gradients is predicated on our ability to precisely emulate their evolution and regulation in 
controlled biophysical environments. Indeed, chemotaxis (the directed movement of cells in 
response to a chemical gradient) and morphogenesis (the concentration-dependent 
specification of cellular differentiation) are two phenomena driven largely by chemical 
gradients.[2,3]
Over the past several decades, multiple approaches have been developed to subject 
eukaryotic as well as prokaryotic cells to concentration gradients. Following the popular 
Boyden chamber that uses a porous insert to form a gradient by means of media 
compartmentalization,[4] numerous techniques improved on the concept, including the 
Zigmond or Dunn chambers, allowing live cell imaging.[5,6]
The application of soft lithography to the formation of microfluidic devices has vastly 
improved our ability to control concentration gradients,[7,8] along with a variety of other 
stimuli.[9–11] Flow-based devices are able to shape the gradient profiles over extended 
periods of time,[12–14] although the cultured cells are subjected to the added influence of 
shear stress. Relying on pure chemokine diffusion, other designs, often consisting of rows of 
microgrooves that isolate the medium channels from the cell chambers, alleviate the issue of 
shear stress while conserving the presence of steep gradients.[15–17] This approach was used 
to generate multidirectional gradients in solution for adherent, two-dimensional (2D) 
cultures.[18] A few groups proposed microfluidic devices capable of forming 
reversing,[19–21] oscillatory[22] or rotating gradients[23–25] in solution, although they were 
exclusively used in the context of chemotaxis in suspended or on adherent cultures 
(reviewed in [26,27]). The recent development of microfluidic devices capable of applying 
concentration gradients to three-dimensional (3D) hydrogel-based cell culture 
systems [15,28–32] not only increased the physiological relevance of such platforms, but it 
also made it possible to recapitulate tissue functions previously unattainable, such as the 
formation of a microvasculature [33,34] or the guidance of axons by chemotactic factors. [35]
Here, we describe a platform design that combines a 3D culture chamber with the ability to 
generate orthogonal linear gradients within the gel region. Two versions of the design are 
proposed, one aimed at forming simultaneous orthogonal gradients of two different 
molecules, the other capable of rotating by 90° an already established linear concentration 
profile. After characterizing the formation, stability and dynamics of the orthogonal 
gradients, we demonstrate their ability to induce a cellular response in contexts particularly 
relevant to multidirectional chemical gradients. The first application recapitulates the 
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localized differentiation of motor neurons in the developing neural tube by exposing mouse 
embryonic stem (ES) cells embedded in a collagen matrix to a combinatorial set of 
morphogen concentrations. The second application makes use of the 90° rotation of a linear 
gradient of chemokines to probe, for the first time, the time scale associated with 3D 
chemotactic adaptation of a population of cancer cells.
2. Results and discussion
2.1. Simultaneous or sequential orthogonal linear gradients can be stably generated in a 
3D hydrogel
Static device—The cross-shaped design of this microfluidic platform (Figure 1) allows for 
the formation of a diffusion-driven linear gradient within its central gel region and its 
symmetry by a 90° rotation results in the ability to simultaneously (Figure 1a–c) or 
sequentially (Figure 1b, Figure S1) generate a second orthogonal gradient. This principle 
was experimentally validated by flowing in the medium channels two fluorescently-labelled 
dextrans, with diffusion coefficients representative of the morphogens and growth factors 
used in this study, and by monitoring the fluorescent signal as a way to assess their 
concentration.[36] The 70 kDa FITC-dextran, flowing in the top channels, established a 
vertical gradient (Figure 2ai) while the 3 kDa Texas Red-dextran, introduced via the right 
channels, developed into a horizontal gradient (Figure 2aii), orthogonal to the first one 
(Figure 2aiii). The time course of the concentration is plotted in Figure 2c, and was used to 
determine the diffusion coefficients of both dextrans, values that were consistent with past 
characterization of dextran diffusion in aqueous solutions.[37,38] Both dextran diffusion 
experimental assays behaved very similarly to what theory predicts, as assessed by 
computational simulations conducted on a simplified geometry (Figure 2b). The steadiness 
of the Texas Red-dextran at a level close to 50% beyond 5h over a period of 10h 
demonstrates the stability of the concentration profile. The concentration profiles in the 
central region (Figure 2d) were found to be highly linear with R2 values of 0.9997 for the 
simulated result, and 0.9977 and 0.9925 for the FITC-dextran and the Texas Red-dextran, 
respectively. This linearity was the result of a pure diffusive process, guaranteed by a 
pressure balance across all reservoirs made possible by the y-junctions.
Computational simulations also allowed for characterization of the influence of the diffusion 
coefficient and flow rate on the concentration profiles. The range of diffusion coefficients 
was chosen to reflect the diffusivity of species used in the present study, and the flow rates 
were varied within values that were considered reasonable given the duration of the studies 
and the hardware constraints imposed by the experimental set-ups. Although the geometry 
of the system is symmetrical by a 90° rotation, the finite diffusive boundary layer gives rises 
to two slightly different solutions for the horizontal and vertical gradient configurations 
(Figure S6a). It was found that the concentration at the gel/medium interface at the furthest 
point along the channel (CX), where the boundary layer is likely to be the thickest, increased 
slightly over the range of diffusion coefficients chosen, by no more than 4% of the 
maximum concentration (Figure S6b). CX followed an opposite trend with respect to the 
flow rate with a value of 1 μL.min−1 providing a reasonable compromise between our desire 
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to maintain symmetric concentration distributions and to minimize the required volume of 
medium (Figure S6c).
Dynamic device—Computational and fluorescent dextran-based characterizations were 
also conducted on the dynamic version of the platform. Figure 3a and movie S1, S2 and S3 
illustrate how switching the concentrations in 2 diagonally opposite channels by redirecting 
the flow via the membrane-valve system, rotates the gradient over time within the gel region 
by 90°. Quantitative comparison of the simulated and experimental time course of the 
concentrations at 5 locations of the central gel region exhibited excellent agreement (Figure 
3b). The simulation reveals that, if averaged over the central region, the angle Θgrad that a 
local gradient makes with the x-axis takes ~10, 20 and 40 min to reach 45° for a molecule of 
diffusivity 20, 10 and 5×10−7 cm2.s−1, respectively (Figure 3c).
We note that reducing the width of the gel region from 1.5 to 1 mm reduced the time to 
reach the initial steady state by a factor of 0.53. Moreover, regardless of the gel region 
width, the time to reach the second steady state after gradient rotation is reduced by a factor 
of 0.52 compared to the first steady state, resulting in a faster gradient turning than initial 
establishment (Figure 3b). This factor can be predicted by a scaling analysis: because the 
center point of the gel region remains constant at 50% of the bulk at all times once the first 
steady state is reached, the characteristic length of the diffusion process changes from the 
width of the region W to half its diagonal . Since the diffusion time scales as the 
square of the distance, this leads to a theoretical gradient rotation time scale that is 
approximately half of that to first establish it.
2.2. Orthogonal gradients of retinoic acid and smoothened agonist can emulate the 
localized differentiation of motor neurons in the developing neural tube
The developing neural tube, the primordial structure for the central nervous system, is a 
polarized hollow elliptical cylinder that runs along a caudal-cranial axis in the vertebrate 
embryo. Retinoic acid (RA), produced in the somites, diffuses laterally into the neural tube 
to form a rostro-caudal gradient that is responsible for caudalizing the neuroepithelium and 
giving rise to spinal progenitors.[39,40] The notochord, a cylindrical structure lining the 
neural tube ventrally, and the floor plate, the most ventral part of the neural tube secrete the 
morphogen sonic hedgehog (SHH), forming a gradient that specifies progenitor identities in 
a concentration dependent manner[41] (Figure 4a). The combinatorial effect of those two 
orthogonally distributed morphogens contributes to the specification of the fate of the ventral 
spinal cord neurons,[42] and specifically motor neurons which arise in the presence of both 
RA and a high concentration of SHH, as evidenced both in vivo and in vitro.[40,43–45] Here 
we demonstrate that the proposed platform can serve as an in vitro model of such a 
phenomenon (Figure 4a), by subjecting ES-derived embryoid bodies (EB) embedded in a 
collagen matrix to two orthogonal gradients of retinoic acid and smoothened agonist (SAG), 
a small molecule activator of the SHH pathway[46,47] and commonly used for motor neuron 
differentiation.[48,49] SAG was preferred to SHH in this study for its higher diffusivity. The 
differentiation efficiency was assessed by measuring the level of GFP, expressed, in the 
HBG3 ES cell line, under the control of the promoter for Hb9, a motor neuron specific 
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transcription factor [40]. First, to validate the ability of the cells to differentiate within a 
collagen matrix and for the morphogens to induce a graded response similar to what was 
found with RA and SHH in past studies,[44,45] the assay was run in a 5 × 5 array of a 96 well 
plate. EBs had formed within the gel by day 2, and, on day 6, after exposure to RA and 
SAG, expression of GFP, indicative of the activation of Hb9, could be observed (Figure 
S7a). The heat map representing the combinatorial effect of RA and SAG not only confirms 
that the absence of either one of the morphogen leads to no motor neuron differentiation 
(consistent with past studies[45,48,50]), it also shows that the differentiation efficiency 
gradually increases with the concentration of both morphogens (Figure S7b and c). More 
importantly, it does so over a linearly increasing range of morphogen concentration, showing 
considerable promise for the microfluidic counterpart experiment below.
Now confident that the two morphogens are capable of differentiating ES cells into motor 
neurons within a 3D collagen gel and inducing a graded response, we conducted the 
experiment in the microfluidic static device described here (procedure detailed in the 
Methods section). Qualitatively, we notice that the macroscopic GFP signal, expressed, in 
Figure 4b, as the local fluorescent signal relative to the negative (absence of morphogens) 
and positive (uniform concentration of morphogens) controls, and representative of its local 
expression and indicative of the differentiation efficiency, is lower in the two branches of 
low exposure to the morphogens (Figure 4b, Figure S8ai) compared to the top-right part of 
the device, where levels of expression reach that of the positive control (Figure 4b, Figure 
S8ai, Figure S9). Note that data were collected in all four branches along with the central gel 
region to expand the ranges of concentration included in the quantitative analysis (Figure S8 
and Methods section). This graded response is even more apparent in the matrix mapping 
(procedure described in the Methods section and Figure S8), where differentiation efficiency 
reaches maximum values in the top-right region of higher RA and SAG concentration 
(Figure 4c). This result is consistent with graded differentiation of adherent neural 
progenitors and 3D ES cells in 1D gradients of SHH generated in microfluidic 
devices.[14,29,51] The negative and positive controls ensured that the presence of the graded 
response was not an artifact of the platform but indeed due to the presence of the orthogonal 
gradients (Figure S9). The uniform GFP expression in the positive control also confirmed 
the absence of increased cell death in the central regions due to hypoxia or impaired nutrient 
transport. We also verified, by monitoring the displacement of individual GFP-positive cells 
via a time lapse recording of the entire differentiation process, that, although cells were 
found to be motile within their own neurospheres, did not migrate past the boundaries of the 
neurospheres. Therefore, these movements could not account for the overall graded 
response, and confirm that the graded differentiation efficiency was a consequence of the 
morphogen gradients. Contrary to well plate assays where the concentration discretization of 
the analysis is limited by the number of wells, applying a continuous range of concentration 
enables the users to decide a posteriori the binning size of the data analysis. Figure 4d shows 
four examples for a subdivision of the 0–100% concentration range into 2, 5, 7 and 10 
intervals. For a coarse interpretation of the result, the 4 quadrant representation illustrates 
how the motor neuron differentiation pathway, quantitatively assessed here by GFP 
expression, effectively acts, in Boolean logic terminology, as an AND gate for the couple 
RA/SAG (Figure 4d and e) and confirms previous studies on mouse and human ES 
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cells.[40,45] A smaller binning size displays the concentration dependence of the 
differentiation process at a finer scale, here plotted along the first diagonal of the matrix 
(Figure 4d and f). It should be noted, however, that the bin size cannot be decreased beyond 
a point where the dimensions of the corresponding averaging area becomes smaller than the 
characteristic length of the investigated objects. In this instance, the average EB diameter of 
160 μm determines a lower bound for the bin size, so the 1.5 mm wide gel region should be 
divided into no more than ~10 domains.
Another advantage of this platform is that it allows for cell-cell signaling between arising 
lineages, which, in contrast to well plate assays, better mimics the in vivo counterpart of an 
emulated tissue. It is likely that such paracrine interactions would contribute to differences 
observed between our motor neuron differentiation experiments within the microfluidic 
platform and the well plate assay. Moreover, while well plate and dish assays for adherent 
cultures remain the most convenient in vitro platforms, the more physiologically relevant 3D 
hydrogel cultures in such traditional platforms lack geometrical controllability. For those 3D 
cultures, microfluidic systems represent an attractive alternative, and, with automation of 
medium supply and data acquisition, could compete with the throughput of traditional 
assays.
Although a linear concentration profile has the advantage of exposing cell populations to a 
uniform gradient, many concentration-dependent biological phenomena occur over several 
orders of magnitude of the concentration of the molecule of interest, due to the inherent 
kinetics of the ligand-receptor complex and signaling cascade. This represents a potential 
limitation of our platform relative to well-plate assays since the latter would be more 
amenable to log-scale variations in concentration. Another limitation is the inherent sample-
to-sample variability of the results compared to the smaller variation in the averages 
obtained with a well plate assay, explained by the larger dimension of the averaging regions. 
One way to compensate for this would be to use multiplexed microdevices.
2.3. Sequential orthogonal gradients can probe chemotactic response time
Cancer cell migration is a critical step in the metastatic cascade. It dictates how cells escape 
from the primary tumor and reach the blood or lymphatic circulation during intravasation, or 
how they migrate away from the vasculature at a distant site to form secondary metastases. 
A variety of cues are responsible for guiding this migration within the tumor 
microenvironment,[52] including chemical gradients via chemotaxis. We therefore tested the 
ability of our platform to expose a highly metastatic fibrosarcoma cell line HT1080[53] to a 
dynamic gradient and investigate the time scale associated with the response to a new 
chemical environment.
Four conditions were compared: (i) uniform serum-free medium, (ii) uniform 20% fetal 
bovine serum (FBS) medium, (iii) a static linear gradient (from 0 to 20% FBS, pointing to 
the right) and (iv) a rotating gradient (from 0 to 20% FBS, 8 h directed to the right followed 
by 7 h pointing up) (Figure 5a). Each trajectory shown represents the center of mass for the 
entire cell population tracked within the central gel region (Figure S10a). Tracked through 
images acquired by epifluorescence microscopy, these trajectories are equivalent to a 
projection on the x-y plane, although minimal migration is occurring in the z-direction. In 
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the absence of gradients, cells migrated randomly, while cells subject to the gradient 
migrated towards the high concentration (Figure 5a, c and d, Figure S10b and c), validating 
the ability of the platform to recapitulate 3D chemotaxis.[12,54]
Upon gradient rotation, we observed that the cells first continued migrating from left to 
right, then transitioned to a bottom-to-top trajectory following a change in the gradient 
direction after a short lag period (Figure 5a). This rotation of the direction of migration was 
quantitatively illustrated by comparing cell distribution Δy (Figure 5d) and the average 
displacements δ (Figure S10b and c) along y-axis between the static and dynamic cases. The 
forward migration index in the y-direction, as measure of the efficiency of forward migration 
transitioned from 4.4×10−3 to 90.6×10−3.
We monitored cell speed V to ensure that the cells had reached their steady state migratory 
behavior before rotating the gradient. We found that all conditions began with migration 
speeds between 13 and 17 μm.h−1. While cells subject to serum-free medium remained at a 
speed of 13 μm.h−1, those exposed to 20% FBS medium, to the static gradient, or to the 
rotating gradient gradually increased their speed to values between 23 and 25 μm/h within 
~4 h as FBS diffused into the gel region (Figure 5b). This chemokinesis phenomenon and 
the measured migration speeds were consistent with studies conducted with different cancer 
cell lines.[54,55]
Besides simply demonstrating a qualitative change in the migratory orientation, the ability to 
track single cell trajectories over time allows for quantification of the population migratory 
dynamic adaptation. The angle Θmig made by the migration direction of the center of mass 
with the x-axis (Figure 5e) for both the static gradient case remained centered around 0°, 
consistent with the trajectories of Figure 5aiii, while in the dynamic case, it started rising 
soon after the gradient began to rotate and eventually reached values close to 90°. If reaching 
the 45° line is used to characterize the time scale of direction change, the response of the cell 
population migration is observed ~250 min (4.15 h) after switching the concentration 
gradient. These data are to be compared with the time needed for the gradient itself to rotate. 
As mentioned above, species with diffusion coefficients in the ranges of 5 to 20×10−7 
cm2.s−1 would take between 10 and 40 min to rotate (i.e. to reach on average 45°). Although 
the FBS constituents responsible for chemotaxis are not entirely known (growth factors like 
EGF being putative candidates), their diffusion coefficients likely fall within the range of the 
ones simulated here (for instance, DEGF = 12–15×10−7 cm2.s−1[56]). It is therefore safe to 
assume that time needed for the cell population to sense the gradient rotation and 
significantly adapt their migration direction is between ~210 min (3.5 h) and ~240 min (4 h). 
This time lag translates into a residual migration along the x-axis after the gradient had 
rotated to become parallel to the y-axis (Figure S10d). Our mode of perturbation of the local 
chemical environment by gradient rotation minimally alters the other characteristics of the 
concentration profile; the average concentration in the central gel region remains constant 
during the switching process (Figure S6d) and the average amplitude Γ of the local gradients 
does not decrease by more than 25% of its steady state value (Figure S6e).
Since this platform is, to our knowledge, the first of its kind to allow the investigation of 
chemotactic dynamics in 3D, existing comparable data are scarce. In adherent cultures, 
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HL60 and neutrophils subject to alternating gradients of CXCL8 and IL-8, respectively, 
were found to reverse migration direction within a few minutes upon gradient 
inversion.[20,21] On the other hand, when exposed to interstitial flow, MDA-MB-231 cancer 
cells embedded in a collagen matrix took 36 h to align with the direction of flow.[57] These 
time scales differ by approximately one order of magnitude either way from the few hours 
we observed for the HT1080 cells in 3D, suggesting that different mechanisms pertain.
3. Conclusion
We successfully demonstrated the ability of the proposed device to generate simultaneous or 
time-dependent linear gradients within a 3D cell culture chamber. This new method of 
shaping the chemical microenvironment allowed us to emulate the localized appearance of 
motor neurons in the developing neural tube under the effect of morphogen gradients. 
Similar concentration profiles could be of use to investigate the combinatorial effects of 
molecules of interest, to mimic in vivo organogenesis and give rise to more complex and 
physiologically relevant tissue models. It is also unique in its ability to expose cells to ranges 
of concentrations of two molecules varying independently of each other, a feature that would 
not be possible in parallel or anti-parallel 1D gradient platforms and is therefore useful in 
probing the synergistic action of drugs or growth factors.
The dynamic version of the device was applied to the study of the chemotactic adaptation of 
cancer cells, which was found to occur at a time scale on the order of 4 h. Single cell 
analysis would allow for the monitoring of receptor repolarization, protrusion dynamics or 
morphological adaptation. Other migratory phenomena could benefit from this technology, 
including immune cell response and the dynamics of growth cone steering by 
chemoattractants.[58]
4. Materials and Methods
4.1. Device design
The static version of the proposed device consists of a cross-shaped, 1.5-mm-wide and 300-
μm-thick, central gel region, lined by trapezoidal posts, and flanked by 1-mm wide medium 
channels (Figure 1a). The role of the posts is to retain by surface tension the hydrogel as it is 
being injected in its liquid form into the central region. The medium channels serve to 
provide nutrients, remove metabolic waste, and apply specific concentration boundary 
conditions. The device has 4 medium inlets, 4 gel filling ports, and 1 outlet. A first linear 
gradient arises in the central region from the diffusion into the gel of a chemokine flowing 
within 2 adjacent medium channels (Figure 1ci). A second linear gradient, orthogonal to the 
first one, can be generated by perfusing the next 2 adjacent channels with another molecule 
of interest (Figure 1cii). As a result of the device geometry, the concentration profile is 
invariant in the z-direction.
For the dynamic version of the device, the design was modified to perform an on-chip flow 
redirection in order to dynamically adapt the orientation of the gradient. A set of 4 open-at-
rest pressure-actuated membrane valves were added to the design of a bottom microfluidic 
layer and were actuated via a top control layer (Figure 1b). Alternating the actuation of 
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opposite pairs of valves, from V1 and V3 to V2 and V4 (Figure S1) directs the fluid coming 
into inlets I2 and I3 to supply either one of the diagonally opposite medium channel around 
the gel region, while leaving the medium coming from inlets I1 and I4 unaltered, allowing 
for 2 gradient configurations, orthogonal to one another (Figure S1). To ensure hydrostatic 
pressure balance across the gel region that could arise from heterogeneous medium channel 
lengths and to prevent fluid convection that would skew the linear nature of the gradient, the 
width along medium channels was modified to compensate length variation. This yielded a 
match, across all channels between resistivity values that scale as , where ds is an 
element of contour along the medium channel, w(s) is the channel width at the position s, 
and h is the constant height of the channel.[59]
4.2. Wafer and PDMS device fabrication and assembly
The fabrication of the wafers and devices was carried out similarly to procedures previously 
reported.[57,60,34] Briefly, molds were made by photo polymerizing a layer of SU-8 
photoresist (MicroChem, MA) on a 4-inch silicon wafer. Upon completion of SU-8 
development, the wafer was silanized to render the surface non-adhesive. All microfluidic 
chips were made out of a 10:1 mix of Polydimethyldiloxane (PDMS) (Sylgard 184, 
Ellsworth Adhesives, Germantown, WI) and curing agent.
Static version—The PDMS was poured onto the mold and, after ~30 min of degassing in 
a desiccator, was allowed to polymerize at 80°C for a minimum of 2 h. Subsequently, the 
PDMS was extracted from the mold and individual devices were cut from the PDMS with a 
3.5 cm cylindrical punch. Medium, gel filling and outlet ports were created using 4, 1 and 2 
mm biopsy punches, respectively. After wet and dry sterilization of the device, the surface 
was treated with plasma (Harrick Plasma, NY) for 45 s, then bonded to a glass slide. 
Immediately after plasma bonding, all channels were filled with PBS containing 1 mg/ml of 
poly-D-lysine (PDL) to enhance adhesion of the collagen matrix to the walls of the gel 
region. Devices were incubated overnight, then washed three times with DI water and 
allowed to dry and recover hydrophobicity for 1 day.
Dynamic version—Prior to silanization of the wafer of the microfluidic layer, the bottom 
part of the microfluidic channels facing the valve control area was made trapezoidal to 
improve the sealing by gently scraping out a wedge of SU-8 near the wafer with a gauge 26 
needle at a 35° angle (Figure S2). This was facilitated by the rather thick channel layer. This 
simple method alleviated the need for cumbersome fabrication techniques to obtain rounded 
channels[61] and allowed for localized wafer modification contrary to full wafer reflow 
techniques.[62]
The control layer was fabricated in the same way as the static device. Access ports were 
punched with a diameter of 2 mm. To form the thin membranes serving as valves, the 
microfluidic bottom layer was generated by positioning a silanized transparency sheet on top 
of some uncured PDMS poured over the wafer, while avoiding trapping bubbles, and 
applying pressure with a flat weight; a method similar to a previously published one.[63] The 
presence of 4 supports, ~ 100 μm taller than the microfluidic channels, ensured a consistent 
membrane thickness throughout the wafer (Figure S3a, right). Upon curing, the plastic sheet 
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was gently peeled off, resulting in a flatter profile than obtained by spin coating the wafer, 
which tends to cause variations in the surface height (Figure S3a, left). The bottom surface 
of the control devices and the top surface of the microfluidic layer (still on the wafer) were 
plasma treated for 45 s and assembled under a stereomicroscope to ensure proper alignment. 
The PDMS was gently cut with a scalpel at the dimensions of the control device and the 
two-layer device was peeled off of the wafer. A 1-mm biopsy punch was used to form the 
gel filling ports and remove the membrane blocking the bridge area allowing the fluidic 
channels to cross each other (Figure S3b). The outlet and inlet ports were formed with 2-mm 
and 2.5-mm biopsy punches, respectively. The formation of the inlet ports was guided by a 
template to ensure proper fitting with the medium reservoir (Figure S4b). The devices were 
then plasma treated and assembled onto a glass slide before being sterilized for cell culture.
4.3. Gel filling and cell seeding
For both versions of the device, rat tail type I collagen (Corning) was used as the culture 
scaffold. 10x PBS containing phenol red, NaOH (0.5 N), DI water and collagen were mixed 
on ice, in that order, in ratios that would dilute the concentrated collagen stock solution 
(ranging from 3 to 4 mg/ml) to a 2 mg/ml, isotonic solution of pH 7.4.
For characterization experiments, plain gel solution was injected to the devices through the 
gel filling ports with a 20 μl pipette tip. To prevent pressure increase that would result in the 
gel solution bulging out of the gel region, the solution was injected through each of the 4 
branches of the gel region, one at a time. The device was then placed in a humidity box to 
prevent evaporation and the gel allowed to polymerize in the incubator for 20 min, after 
which medium or PBS was backfilled from the outlet into the medium channels. The devices 
were left in the humidity chamber until used.
For the experiments involving cells, the same 2 mg/ml mixture was used to resuspend a 
pellet of cells in order to reach an appropriate cell density for each experiment. To prevent 
cells from settling on the floor of the device during polymerization, the devices were rotated 
upside down for 4 min, before being rotated upright for the remaining 16 min.
In the dynamic version of the device, prior to gel seeding, the valves were pre-filled by 
compressing PBS into the control channels for ~20 min. The gas permeability of PDMS 
allowed for the liquid to chase air and to fill up the dead-end channel, preventing bubble 
from forming upon actuation of the valves.
4.4. Cell culture
Mouse ES cells HBG3 (HB9-GFP), a kind gift from Pr. Hynek Wichterle, Columbia 
University, NY, were cultured on a confluent monolayer of mouse embryonic fibroblasts 
(Applied StemCell, CF-1 MEF Feeder Cells, P3, irradiated, ASF-1217), plated on gelatin 
coated dishes, in culture medium consisting of Embryomax ES Dulbecco's Modified Eagle's 
Medium (DMEM) (Millipore Chemicon), 15% ES-qualified fetal bovine serum (FBS) 
(Invitrogen), 1% nucleosides (Millipore Chemicon), 1% non-essential amino acids 
(Millipore Chemicon), 1% penicillin-streptomycin (Invitrogen), 1% L-glutamine 
(Invitrogen), 0.1 mM β-mercaptoethanol (Sigma), 0.1% leukemia inhibitory factor (EMD 
Millipore, LIF2010).[48] HT1080-mCherry-H2B fibrosarcoma cells[28] were cultured in 
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DMEM (Invitrogen) supplemented with 10% FBS, 1% L-glutamine and 1% penicillin-
streptomycin.
4.5. Orthogonal gradient and differentiation assay: set-up and data acquisition
ES cells were trypsinized and preplated for 30 min onto 0.1% gelatin coated dishes to 
eliminate fibroblasts and differentiated cells. The non-adherent cells were collected, counted, 
spun down and resuspended in the collagen gel at a density of 1×106 cells/ml before being 
seeded into the PDL-coated devices (see “gel filling” section above). Upon gel 
polymerization, differentiation medium was supplied to the medium channels. The 
differentiation medium consisted of 1:1 Advanced DMEM/F-12 (Invitrogen) / Neurobasal 
(Invitrogen), 10% knockout serum replacement (Invitrogen), 1% penicillin-streptomycin, 
1% L-glutamine, β-mercaptoethanol (0.1 mM).[48] On day 2, tubing and reservoirs were 
mounted onto the devices (see “tubing and reservoir assembly” section). The devices were 
placed back into the incubator and the reservoirs were slightly backfilled with plain medium 
at a flow rate of 100 μL.min−1 via a syringe pump (Harvard Apparatus, Cambridge, MA). In 
order to prevent extensive medium circulation and mixing during reservoir fill up, the 
medium was supplied with a custom-made square-shaped pipet tip adapter mounted to a 
linear multichannel pipettor (Figure S4aiii). The orthogonal gradient was formed by 
supplementing the media with retinoic acid (RA) (Sigma), and smoothened agonist (SAG) 
(EMD). From bottom left and in a clockwise order, the morphogens were supplemented as 
such: nothing, RA, RA+SAG and SAG. Both were supplied at a concentration of 1 μM, as 
suggested in the literature as the optimum dosage for motor neuron differentiation.[48] A 
total of 3 ml was supplied to each reservoir. An initial 0.5 ml/reservoir was purged at 100 
μL.min−1, after which flow rate was set to 4 μL.min−1. Medium was replenished with 2 ml 
after 36 hours. On day 5, medium was replaced by plain differentiation medium 
supplemented with 10 ng/ml of both glia-derived neurotrophic factor (GDNF) (R&D 
systems) and ciliary neurotrophic factor (CNTF) (R&D systems). After each medium 
change, flow rate was increased temporarily to reset the boundary conditions. By day 6, 
devices were fixed with 4% paraformaldehyde and imaged by confocal microscopy 
(Olympus FV-1000). To minimize the scanning time and because images will subsequently 
be projected along the z axis, the pinhole was wide open at 800 μm diameter increasing the 
depth of field. Eight slices were acquired per tile for a total of 32 tiles to cover the entire gel 
surface area.
4.6. Rotating gradient and migration assay: set-up and data acquisition
Migration experiments were conducted after the HT1080 cells, seeded at a density of 
0.5×106 cells/ml, recovered overnight in starving medium consisting in 0.5% FBS in order 
to reduce migration and matrix degradation. The chemotactic gradients were generated by 
supplying 2 adjacent channels with FBS-free medium, while the medium in the opposite 2 
channels contained 20% FBS along with 70 kDa dextran-FITC to monitor the formation and 
stability of the gradient throughout the experiment. After bubble removal (see “bubble 
removal” section) and tubing and reservoir assembly (see “tubing and reservoir assembly” 
section) the devices were placed on the stage of a Axiovert 200 inverted microscope (Zeiss, 
Germany) contained in a humidified and CO2- and temperature-controlled environmental 
chamber. Outlet tubing was connected to a syringe pump and the valves were pressurized by 
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placing a mass on a vertically oriented 10 ml syringe resulting in a power-free steady 
pressure of 12 Psi. An initial flow rate of 100 μL.min−1 was applied for 2 min to purge the 
channels and establish proper boundary conditions, then reduced to 4 μL.min−1. Phase 
contrast, mCherry and GFP images collected at the mid-plane with a 10x objective were 
acquired every 15 min for 16 h with the Axiovision software (Zeiss). For the experiments 
with gradient rotation, the valves were switched at t = 8 h and the flow rate was increased to 
100 μL.min−1 for 2 min to purge the channels from the previous media.
4.7. Bubble removal
Complete bubble removal from the medium, gel filling ports and control channels was 
crucial to prevent bubble growth that would, in turn, lead to gel destruction or flow 
obstruction. We employed a technique inspired by [64]. However, instead of applying 
compressed fluid directly into the channel that would cause delamination of the PDMS 
layers, the entire device, immersed in pre-warmed PBS, was pressurized in a custom-made 
polycarbonate chamber at ~16 psi for 20 min (Figure S5a). This procedure completely 
removed all bubbles with no adverse effect on cell survival or behavior (Figure S5b). Failure 
to immerse the device in PBS would result in reappearance of the bubbles within 5 min 
following pressure release (Figure S5c and d).
4.8. Statistical analysis
Statistical analysis was done in Prism (Graphpad Software, Inc, San Diego, CA). Statistical 
significance analysis was conducted with ANOVA and all tests resulting in a p-value less 
than 0.05 were considered statistically significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Microfluidic design and principle of orthogonal gradient generation
(a) The static version of this microfluidic device consists of a cross-shaped gel region lined 
by trapezoidal posts and flanked by medium channels. (b) The dynamic version consists of a 
two-layer device: a bottom microfluidic layer featuring the same cross-shaped gel region and 
a top control layer allowing for valve actuation as well as serving as a bridge. (c) Illustration 
of the formation of two concentration gradients orthogonal to each other. Arrows indicate 
the direction of flow. All scale bars: 5 mm.
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Figure 2. Experimental and computational gradient characterization in the static device
(a) Experimental demonstration of the formation of two orthogonal gradients obtained with 
70 kDa FITC-dextran (green) and 3 kDa Texas Red-dextran (red). (b) Gradient formation 
simulated in the simplified computational model, illustrated by a heat map representing the 
fraction of the bulk concentration (C0). (c) Time course of the concentration C at the center 
point of the gel region (point C in aii-aiii), expressed as a fraction of the bulk concentration 
(C0), for 70 kDa FITC-dextran (green) and 3 kDa Texas Red-dextran (red) compared to the 
simulated profiles for molecules of diffusion coefficient 5×10−7 (green dashed line) and 
12.5×10−7 cm2/s (red dashed line). (d) Steady state linear concentration profiles plotted 
between points A and B (aii-aiii) as afunction of the distance d for both dextran molecules 
compared to the simulated profiles. Shaded bands in (c) and (d) represent standard deviation. 
All scale bars: 1 mm.
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Figure 3. Experimental and computational gradient characterization in the dynamic device
(a) Experimental and simulated concentration profiles before, during and after gradient 
rotation. Each arrow represents the local concentration gradient direction and amplitude. (b) 
Time course of the concentration expressed as a fraction of the bulk (C/C0) at 5 points 
within the gel region (as shown in (a)) for 70 kDa FITC-dextran (green) and 3 kDa Texas 
Red-dextran (red) compared to the simulated profiles for molecules of diffusion coefficient 
5×10−7 (green dashed line) and 12.5×10−7 cm2/s (red dashed line). Black arrows indicate 
gradient switch. (c) Time course of the average angle Θgrad formed between the simulated 
gradient direction and the x-axis for 3 different diffusion coefficients. Shaded bands and 
error bars represent standard deviation.
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Figure 4. Demonstration of the effect of orthogonal gradients of retinoic acid (RA) and 
smoothened agonist (SAG) on the localized differentiation of motor neurons
(a) Schematic comparing the morphogen concentration profiles in the developing neural 
tube and their counterpart in the microfluidic device. (b) Heat map representing the local 
expression of GFP expression in the neurospheres normalized by the average GFP 
expression in the positive and negative controls control (E-Eneg/Epos-Eneg). Average of two 
replicates, each comprised of 3 devices. Scale bar: 2 mm. (c) Matrix representation of the 
heat map in (b). Each value corresponds to the local average calculated over the range of 
concentrations showed on the x- and y-axes, as detailed in Figure S8 (black squares indicate 
excluded data, see Methods section). Stars indicate a statistically significant result with 
respect to the maximum data point (p<0.05). (d) Four matrix representations with varying 
binning size (black squares indicate excluded data). (e) Quadrant analysis of the result in (b) 
for a binning size of 50% ((d), 2×2). (f) Graph representing the relative GFP expression 
along the diagonal y=x as a function of the concentration C of RA and SAG for a binning 
size of 10% ((d), 10×10) (pos: positive control, grad: orthogonal gradients, neg: negative 
control). All error bars: SEM, ns: not significant.
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Figure 5. Demonstration of the effect of gradient rotation in the chemotaxis of HT1080 cells
(a) Trajectories of the centers of mass for the 4 tested conditions (each condition is the 
average of 4 replicates). The grey triangles indicate the direction of the gradient. The yellow 
dots indicate the beginning of gradient rotation. (b) Time course of the average migration 
speed V. (c) Final cell distribution Δx along the x-axis with respect to their initial position. 
(d) Final cell distribution Δy along the y-axis with respect to their position at t = 8 h (e) Time 
course of the average cell migration angle Θmig (red) and simulated gradient angle Θgrad 
(blue) with respect to the x-axis. U: uniform, Stat: static gradient, Dyn: dynamic gradient. 
Shaded bands and error bars indicate standard errors, ns: not significant.
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